Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
17 September, 2026
Meet the TROG Quality Assurance team
TROG UPDATES: 17 September 2026 Our Quality Assurance team
17 September, 2026
TROG trial of new lung cancer radiation therapy approach opens
LATEST NEWS: 17 September 2026 The first Australian site